{"id":"https://openalex.org/W4281629035","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.512","title":"Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer: Results from the NeoSTAR trial.","display_name":"Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer: Results from the NeoSTAR trial.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281629035","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.512"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.512","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.512","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.512","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018738915","display_name":"Laura M. Spring","orcid":"https://orcid.org/0000-0001-8904-3514","observed_orcids":["https://orcid.org/0000-0001-8904-3514"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Spring","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069056507","display_name":"Sara M. Tolaney","orcid":"https://orcid.org/0000-0002-5940-8671","observed_orcids":["https://orcid.org/0000-0002-5940-8671"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara M. Tolaney","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080772475","display_name":"Neelam Vijay Desai","orcid":"https://orcid.org/0000-0001-8641-0542","observed_orcids":["https://orcid.org/0000-0001-8641-0542"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neelam Vijay Desai","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA;","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023833214","display_name":"Geoffrey G. Fell","orcid":"https://orcid.org/0000-0001-6436-6691","observed_orcids":["https://orcid.org/0000-0001-6436-6691"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Fell","raw_affiliation_strings":["Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075153453","display_name":"Lorenzo Trippa","orcid":"https://orcid.org/0000-0001-5218-5666","observed_orcids":["https://orcid.org/0000-0001-5218-5666"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lorenzo Trippa","raw_affiliation_strings":["Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032332609","display_name":"Amy H. Comander","orcid":"https://orcid.org/0000-0002-1644-9297","observed_orcids":["https://orcid.org/0000-0002-1644-9297"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy H. Comander","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019296224","display_name":"Therese Marie Mulvey","orcid":"https://orcid.org/0000-0002-7364-2835","observed_orcids":["https://orcid.org/0000-0002-7364-2835"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Therese Marie Mulvey","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075477385","display_name":"Shannon McLaughlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon McLaughlin","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052031831","display_name":"Phoebe K. Ryan","orcid":"https://orcid.org/0009-0005-3093-0844","observed_orcids":["https://orcid.org/0009-0005-3093-0844"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phoebe Ryan","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074484298","display_name":"Aron S. Rosenstock","orcid":"https://orcid.org/0000-0003-2500-7674","observed_orcids":["https://orcid.org/0000-0003-2500-7674"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aron S. Rosenstock","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024995771","display_name":"Ana Christina Garrido-Castro","orcid":"https://orcid.org/0000-0002-5989-6636","observed_orcids":["https://orcid.org/0000-0002-5989-6636"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Christina Garrido-Castro","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003348942","display_name":"Filipa C. Lynce","orcid":"https://orcid.org/0000-0001-6615-7076","observed_orcids":["https://orcid.org/0000-0001-6615-7076"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Filipa Lynce","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017550097","display_name":"Beverly Moy","orcid":"https://orcid.org/0000-0003-3472-1140","observed_orcids":["https://orcid.org/0000-0003-3472-1140"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beverly Moy","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057580348","display_name":"Steven Jay Isakoff","orcid":"https://orcid.org/0000-0002-6677-1014","observed_orcids":["https://orcid.org/0000-0002-6677-1014"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven J. Isakoff","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051532432","display_name":"Nadine Tung","orcid":"https://orcid.org/0000-0003-1422-3734","observed_orcids":["https://orcid.org/0000-0003-1422-3734"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadine M. Tung","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA;","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029062544","display_name":"Elizabeth Ann Mittendorf","orcid":"https://orcid.org/0000-0002-9762-8536","observed_orcids":["https://orcid.org/0000-0002-9762-8536"]},"institutions":[{"id":"https://openalex.org/I4210161994","display_name":"Dana-Farber Brigham Cancer Center","ror":"https://ror.org/05rgrbr06","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I4210117453","https://openalex.org/I4210161994","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Mittendorf","raw_affiliation_strings":["Dana-Farber Brigham Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Brigham Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210161994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052735318","display_name":"Leif William Ellisen","orcid":"https://orcid.org/0000-0003-0444-7910","observed_orcids":["https://orcid.org/0000-0003-0444-7910"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leif W. Ellisen","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"512","last_page":"512"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sacituzumab-govitecan","display_name":"sacituzumab govitecan","score":0.9959999918937683},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8930000066757202},{"id":"https://openalex.org/keywords/localized-breast-cancer","display_name":"localized breast cancer","score":0.902999997138977},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9919999837875366},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8859999775886536},{"id":"https://openalex.org/keywords/trop2","display_name":"TROP2","score":0.8479999899864197},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.8399999737739563},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8840000033378601},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9929999709129333},{"id":"https://openalex.org/keywords/radiological-response","display_name":"radiological response","score":0.7369999885559082},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.8880000114440918},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.915242612361908},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6639819741249084},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.604352593421936},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5911461710929871},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5530484914779663},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.5210418105125427},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5154093503952026},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4847645163536072},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4613613486289978},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.45905742049217224},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.41447803378105164},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.39032354950904846},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3515586853027344},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34991857409477234},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3258257210254669},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28204846382141113},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22016394138336182},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.13031312823295593}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.512","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.512","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.512","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3131174561","https://openalex.org/W4396591204","https://openalex.org/W4389623018","https://openalex.org/W4410808850","https://openalex.org/W4313826298","https://openalex.org/W2595349270","https://openalex.org/W4281785944","https://openalex.org/W3216533424","https://openalex.org/W2791638488","https://openalex.org/W3092870946"],"abstract_inverted_index":{"512":[0],"Background:":[1],"Sacituzumab":[2],"govitecan":[3],"(SG),":[4],"a":[5,23,50,139,190,324,338,355],"novel":[6],"antibody-drug":[7],"conjugate":[8],"in":[9,78,454,464],"which":[10],"the":[11,28,96,164,172,175,253,278,314,426,446,450],"topoisomerase":[12],"1":[13,333,416],"inhibitor":[14],"SN-38":[15],"(active":[16],"metabolite":[17],"of":[18,37,90,95,134,142,174,193,245,250,401,428,472],"irinotecan)":[19],"is":[20,32],"linked":[21],"to":[22,71,166,273,348,411,419],"humanized":[24],"monoclonal":[25],"antibody":[26],"targeting":[27],"tumor":[29],"antigen":[30],"Trop2,":[31],"currently":[33],"approved":[34],"for":[35,61,145,160,207],"treatment":[36,123],"patients":[38,151],"(pts)":[39],"with":[40,63,84,108,120,152,257,281,337,366,456],"pre-treated":[41],"metastatic":[42],"triple":[43],"negative":[44],"breast":[45,79],"cancer":[46],"(TNBC).":[47],"We":[48],"conducted":[49],"phase":[51],"2":[52,330],"study":[53],"evaluating":[54],"neoadjuvant":[55,452],"(NA)":[56],"SG":[57,126,258,282,351,367,408,459,473],"as":[58,157,474,476],"upfront":[59],"therapy":[60,170,409],"pts":[62,217,246,270,296,316,336,402,406,433],"localized":[64,109,465],"TNBC":[65,110,455],"(NCT04230109).":[66],"The":[67,239,293,362],"primary":[68,161],"objective":[69],"was":[70,127,183,260,284],"assess":[72],"pathological":[73],"complete":[74],"response":[75,92,179,192,255,421],"(pCR)":[76],"rate":[77,256,280],"and":[80,98,102,306,332,352,394,439],"lymph":[81],"nodes":[82],"(ypT0/isN0)":[83],"SG.":[85,251,276],"Secondary":[86],"objectives":[87],"included":[88],"assessment":[89],"radiological":[91,254],"rate,":[93],"evaluation":[94],"safety":[97],"tolerability":[99],"(CTCAE":[100],"v5.0)":[101],"event-free":[103],"survival":[104],"(EFS).":[105],"Methods:":[106],"Patients":[107],"(tumor":[111],"size":[112,116],"\u22651cm,":[113],"or":[114,181,414],"any":[115],"if":[117],"node":[118,237],"positive)":[119],"no":[121,158,432],"prior":[122],"were":[124,200,218,368],"eligible.":[125],"administered":[128],"IV":[129],"on":[130,469],"Days":[131],"1,":[132],"8":[133],"each":[135],"21-day":[136],"cycle":[137],"at":[138,171,445],"starting":[140],"dose":[141],"10":[143],"mg/kg":[144],"4":[146,149,234,248],"cycles.":[147],"After":[148],"cycles,":[150],"biopsy-proven":[153],"residual":[154],"disease,":[155,227,311],"considered":[156],"pCR":[159,279,325,356],"endpoint,":[162],"had":[163,297,323,354],"option":[165],"receive":[167],"additional":[168,319],"NA":[169,320,477],"discretion":[173],"treating":[176],"physician.":[177],"Radiologic":[178],"(US":[180],"MRI)":[182],"defined":[184],"by":[185],"RECIST":[186],"version":[187],"1.1":[188],"using":[189],"composite":[191],"CR":[194],"&":[195],"PR.":[196],"Standard":[197],"descriptive":[198],"statistics":[199],"utilized,":[201],"including":[202,480],"95%":[203,265,289,358],"binomial":[204],"confidence":[205],"intervals":[206],"all":[208],"rates":[209],"estimated.":[210],"Results:":[211],"From":[212],"7/14/20":[213],"\u2013":[214],"8/31/21,":[215],"50":[216],"enrolled":[219],"(median":[220],"age":[221],"=":[222,243,263,287,300,304,309,343,372,377,382,387,392,398],"48.5;":[223],"11":[224,231,295],"stage":[225,229,232],"I":[226],"24":[228,315],"II,":[230],"III,":[233],"unknown;":[235],"62%":[236,261],"negative).":[238],"majority":[240],"(98%;":[241],"n":[242,371,376,381,386,391,397],"49)":[244],"completed":[247],"cycles":[249],"Overall,":[252,277],"alone":[259,283],"(n":[262,286,299,303,308,342],"31,":[264],"CI":[266,290,359],"48%,":[267],"77%).":[268],"26":[269],"proceeded":[271,346],"directly":[272,347],"surgery":[274,349],"after":[275,350],"30%":[285],"15/50,":[288],"18%,":[291],"45%).":[292],"other":[294],"RCB-1":[298],"3),":[301],"RCB-2":[302],"5),":[305],"RCB-3":[307],"3)":[310],"respectively.":[312],"Of":[313],"who":[317],"received":[318,327],"therapy,":[321],"6":[322,353],"(3":[326],"anthracycline-based":[328],"regimen,":[329],"carboplatin/taxane,":[331],"docetaxel/cyclophosphamide).":[334],"Among":[335],"germline":[339],"BRCA":[340],"mutation":[341],"8),":[344],"7":[345],"(86%,":[357],"42%,":[360],"99%).":[361],"most":[363],"common":[364],"AEs":[365],"nausea":[369],"(82%,":[370],"41),":[373],"fatigue":[374],"(78%,":[375],"39),":[378],"alopecia":[379],"(76%,":[380],"38),":[383],"neutropenia":[384],"(58%,":[385],"29),":[388],"anemia":[389],"(36%,":[390],"18),":[393],"rash":[395],"(48%,":[396],"24).":[399],"6%":[400],"required":[403],"dose-reduction.":[404],"No":[405],"discontinued":[407,417],"due":[410,418],"disease":[412,435],"progression":[413],"AEs;":[415],"minimal":[420],"per":[422],"investigator":[423],"preference.":[424],"At":[425],"time":[427],"data":[429],"cut-off":[430],"(1/18/22),":[431],"experienced":[434],"recurrence.":[436],"Updated":[437],"biomarker":[438],"EFS":[440],"results":[441],"will":[442],"be":[443],"presented":[444],"meeting.":[447],"Conclusions:":[448],"In":[449],"first":[451],"trial":[453,485],"an":[457],"ADC,":[458],"demonstrated":[460],"single":[461],"agent":[462],"efficacy":[463],"TNBC.":[466],"Further":[467],"research":[468],"optimal":[470],"duration":[471],"well":[475],"combination":[478],"strategies,":[479],"immunotherapy,":[481],"are":[482],"needed.":[483],"Clinical":[484],"information:":[486],"NCT04230109.":[487]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":15},{"year":2022,"cited_by_count":9}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2022-06-13T00:00:00"}